Stefano Cogo Badan

Hospital Israelita Albert Einstein

Papers

1

Total Citations

3

H-Index

1

About

Stefano Cogo Badan is a pioneering urologic oncologist whose research focuses on advancing surgical treatments for testicular cancer, particularly through minimally invasive techniques. His most notable contribution is the introduction and validation of robot-assisted retroperitoneal lymph node dissection (R-RPLND) as a primary treatment for clinical stage II seminoma germ cell tumors—a paradigm shift from traditional radiotherapy and chemotherapy. This work, published in 2024 with 3 citations, addresses the critical need to reduce long-term treatment morbidities in young patients. Cogo Badan’s research demonstrates that R-RPLND offers comparable oncologic control while sparing patients from the toxicities of systemic therapy. His contributions are reshaping clinical guidelines and offering a new standard of care for this patient population. By championing surgical innovation in a historically chemo- and radiation-dominated field, Cogo Badan is driving a movement toward more personalized, less morbid cancer care. His work not only highlights the potential of robotic surgery in complex oncologic settings but also underscores the importance of multidisciplinary collaboration in improving outcomes for young adults facing testicular cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted retroperitoneal lymph node dissection as primary treatment for stage II seminoma germ cell tumor
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Hospital Israelita Albert Einstein

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago